Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Mullen

Showing results (351-360 of 371) with videos related to

Pageof 38
Sort By:
Journal of Diabetes Science and Technology|May 19, 2021
Comparing Patch vs Pen Bolus Insulin Delivery in Type 2 Diabetes Using Continuous Glucose Monitoring Metrics and ProfilesRichard M Bergenstal, Mary L Johnson, Vanita R Aroda, et al.
Cancers|December 10, 2021
Inhibition of AXL and VEGF-A Has Improved Therapeutic Efficacy in Uterine Serous CancerMichael D Toboni, Elena Lomonosova, Shaina F Bruce, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 25, 2003
Interference with T cell receptor-HLA-DR interactions by Epstein-Barr virus gp42 results in reduced T helper cell recognitionMaaike E Ressing, Daphne van Leeuwen, Frank A W Verreck, et al.
Molecular Cancer Therapeutics|May 19, 2022
GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell GlycolysisShaina F Bruce, Kevin Cho, Hollie Noia, et al.
Gynecologic Oncology|July 6, 2024
A toolkit for a modern gynecologic oncology tissue bankOlivia Graham, Jeimmy Rodriguez, Rachel Abbott, et al.
Molecular Cancer Research : MCR|October 21, 2021
GAS6/AXL Inhibition Enhances Ovarian Cancer Sensitivity to Chemotherapy and PARP Inhibition through Increased DNA Damage and Enhanced Replication StressMary M Mullen, Elena Lomonosova, Michael D Toboni, et al.
Molecular Cancer Research : MCR|March 3, 2026
Correction: GAS6/AXL Inhibition Enhances Ovarian Cancer Sensitivity to Chemotherapy and PARP Inhibition through Increased DNA Damage and Enhanced Replication StressMary M Mullen, Elena Lomonosova, Michael D Toboni, et al.
Cancer Discovery|October 8, 2024
The Evolutionary Forest of Pancreatic CancerKatelyn M Mullen, Jungeui Hong, Marc A Attiyeh, et al.
Communications Biology|July 3, 2023
Genetic characterization of primary and metastatic high-grade serous ovarian cancer tumors reveals distinct features associated with survivalEmilee N Kotnik, Mary M Mullen, Nicholas C Spies, et al.
Photobiomodulation, Photomedicine, and Laser Surgery|September 10, 2025
Improvements in Resting-State Functional Connectivity of the Cerebellum after Transcranial Photobiomodulation in Adults with a History of Repetitive Head Acceleration EventsFinian Keleher, Carrie Esopenko, Hannah M Lindsey, et al.
Pageof 38

Showing results (351-360 of 371) with videos related to

Sort By:
Pageof 38
Journal of Diabetes Science and Technology|May 19, 2021
Comparing Patch vs Pen Bolus Insulin Delivery in Type 2 Diabetes Using Continuous Glucose Monitoring Metrics and ProfilesRichard M Bergenstal, Mary L Johnson, Vanita R Aroda, et al.
Cancers|December 10, 2021
Inhibition of AXL and VEGF-A Has Improved Therapeutic Efficacy in Uterine Serous CancerMichael D Toboni, Elena Lomonosova, Shaina F Bruce, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 25, 2003
Interference with T cell receptor-HLA-DR interactions by Epstein-Barr virus gp42 results in reduced T helper cell recognitionMaaike E Ressing, Daphne van Leeuwen, Frank A W Verreck, et al.
Molecular Cancer Therapeutics|May 19, 2022
GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell GlycolysisShaina F Bruce, Kevin Cho, Hollie Noia, et al.
Gynecologic Oncology|July 6, 2024
A toolkit for a modern gynecologic oncology tissue bankOlivia Graham, Jeimmy Rodriguez, Rachel Abbott, et al.
Molecular Cancer Research : MCR|October 21, 2021
GAS6/AXL Inhibition Enhances Ovarian Cancer Sensitivity to Chemotherapy and PARP Inhibition through Increased DNA Damage and Enhanced Replication StressMary M Mullen, Elena Lomonosova, Michael D Toboni, et al.
Molecular Cancer Research : MCR|March 3, 2026
Correction: GAS6/AXL Inhibition Enhances Ovarian Cancer Sensitivity to Chemotherapy and PARP Inhibition through Increased DNA Damage and Enhanced Replication StressMary M Mullen, Elena Lomonosova, Michael D Toboni, et al.
Cancer Discovery|October 8, 2024
The Evolutionary Forest of Pancreatic CancerKatelyn M Mullen, Jungeui Hong, Marc A Attiyeh, et al.
Communications Biology|July 3, 2023
Genetic characterization of primary and metastatic high-grade serous ovarian cancer tumors reveals distinct features associated with survivalEmilee N Kotnik, Mary M Mullen, Nicholas C Spies, et al.
Photobiomodulation, Photomedicine, and Laser Surgery|September 10, 2025
Improvements in Resting-State Functional Connectivity of the Cerebellum after Transcranial Photobiomodulation in Adults with a History of Repetitive Head Acceleration EventsFinian Keleher, Carrie Esopenko, Hannah M Lindsey, et al.
Pageof 38